Amends existing law to update Schedule I.

The Idaho Board of Pharmacy administers the regulatory provisions of the state's Uniform Controlled Substances Act. If any substance is designated, rescheduled, or deleted as a controlled substance under federal law and notice thereof is given to the Board, the Board shall similarly control the substance unless the Board objects to the inclusion, rescheduling, or deletion. This bill mirrors DEA scheduling decisions for 2019, including placing synthetic cannabinoids, synthetic cathinones, and synthetic fentanyls in Schedule I.